Concepedia

Publication | Open Access

Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension

DOIFull Paper Access

454

Citations

26

References

2014

Year

Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra Green, Afshin Salsali, Uli C. Broedl, Hans J. Woerle
Diabetes Care

Abstract

Empagliflozin was associated with significant and clinically meaningful reductions in BP and HbA1c versus placebo and was well tolerated in patients with type 2 diabetes and hypertension.

References

YearCitations

Page 1